Loading
Latest filing published 02 Jan 2018 for H-CYTE, INC., €4,509.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Randal R. Betz in H-Cyte, Inc. We count 6 filings; the first trade dates from 4 December 2015 and the latest from 29 December 2017.
On the market, this insider has only ever bought: 2 purchases, €32k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.
The latest filing, published on 2 January 2018, reports a share grant of €4,509 in H-Cyte, Inc. The clock since the last published purchase (18 July 2017) now reads 3,385 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations